Equity Details
Price & Market Data
Price: $0.913
Daily Change: -$0.0297 / 3.25%
Daily Range: $0.882 - $0.941
Market Cap: $25,547,098
Daily Volume: 205,770
Performance Metrics
1 Week: -5.57%
1 Month: -0.71%
3 Months: -30.34%
6 Months: -48.74%
1 Year: -80.75%
YTD: -50.14%
About Jasper Therapeutics, Inc. (JSPR)
Gain a deep understanding of Jasper Therapeutics, Inc. (JSPR). The stock is trading at 0.913, showing a daily change of -$0.0297 / 3.25%. Its market capitalization is 25,547,098. Performance over 1-week (-5.57%) and 6-month (-48.74%) periods offer valuable insights.
Company Details
Employees: 22
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.